4.6 Review

What primary microcephaly can tell us about brain growth

Journal

TRENDS IN MOLECULAR MEDICINE
Volume 12, Issue 8, Pages 358-366

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2006.06.006

Keywords

-

Funding

  1. Medical Research Council [G108/461] Funding Source: Medline
  2. MRC [G108/461] Funding Source: UKRI
  3. Medical Research Council [G108/461] Funding Source: researchfish

Ask authors/readers for more resources

Autosomal recessive primary microcephally (MCPH) is a neuro-developmental disorder that causes a great reduction in brain growth in utero. MCPH is hypothesized to be a primary disorder of neurogenic mitosis, leading to reduced neuron number. Hence, MCPH proteins are likely to be important components of cellular pathways regulating human brain size. At least six genes can cause this disorder and four of these have recently been identified: autosomal recessive primary microcephally 1 (MCPH1), abnormal spindle-like, microcephaly associated (ASPM), cyclin-dependent kinase 5 regulatory subunit-associated protein 2 (CDK5RAF2) and centromere protein J (CENPJ). Whereas aberration of ASPM is the most common cause of MCPH, MCPH1 patients can be more readily diagnosed by the finding of increased numbers of 'prophase-like cells' on routine cytogenetic investigation. Three MCPH proteins are centrosomal components but have apparently diverse roles that affect mitosis. There is accumulating evidence that evolutionary changes to the MCPH genes have contributed to the large brain size seen in primates, particularly humans. The aim of this article is to review what has been learnt about the rare condition primary microcephally and the information this provides about normal brain growth.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available